ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms
ERBB4 介导的信号传导是 B 细胞淋巴肿瘤对 BTK 和 PI3K 抑制剂产生耐药性的介质
期刊:
影响因子:
doi:10.1101/2023.01.01.522017
Alberto J Arribas, Sara Napoli, Luciano Cascione, Laura Barnabei, Giulio Sartori, Eleonora Cannas, Eugenio Gaudio, Chiara Tarantelli, Afua A Mensah, Filippo Spriano, Antonella Zucchetto, Francesca M Rossi, Andrea Rinaldi, Manuel Castro de Moura, Sandra Jovic, Roberta Bordone Pittau, Anastasios Stath
